Lv2
110 积分 2025-12-12 加入
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
22小时前
待确认
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in patients with moderate-to-severe chronic spontaneous urticaria with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-controlled pilot study
1个月前
已完结
Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis
1个月前
已完结
皖公网安备34019202002308
